IGC Pharma (IGC) Tax Provisions (2010 - 2024)
IGC Pharma (IGC) posted quarterly Tax Provisions of $1.5 million for Q1 2024, up 161.05% year-over-year from $565023.0 in Q2 2023, and up 161.05% quarter-over-quarter from -$2.4 million in Q1 2023.
IGC Pharma (IGC) Tax Provisions (2010 - 2024) Analysis & Trends
IGC Pharma (IGC) has reported Tax Provisions for 12 consecutive years, with $1.5 million the latest figure, recorded in Q1 2024.
- In Q1 2024, Tax Provisions rose 161.05% year-over-year to $1.5 million; the TTM figure through Dec 2024 stood at $1.5 million (up 161.05% YoY), while the FY2025 annual figure was -$2.3 million, down 256.27% from the prior year.
- Tax Provisions improved to $1.5 million in Q1 2024 per IGC's latest filing, from -$2.4 million in the prior quarter.
- Across five years, Tax Provisions topped out at $1.5 million in Q1 2024 and bottomed at -$3.1 million in Q1 2020.
- Historically, Tax Provisions has averaged -$994000.0 across 4 years, with a median of -$1.2 million in 2022.
- Annual changes were most pronounced in 2023 — Tax Provisions sank 4932.0% — and 2024, when it jumped 161.05%.
- IGC Pharma's Tax Provisions stood at -$3.1 million in 2020, then soared by 101.62% to $50000.0 in 2022, then tumbled by 4932.0% to -$2.4 million in 2023, then surged by 161.05% to $1.5 million in 2024.
- Business Quant data shows IGC's Tax Provisions at $1.5 million in Q1 2024, -$2.4 million in Q1 2023, and $50000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.31 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.90 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -90.33 Mn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.48 Mn |
| Mar 31, 2023 | -2.42 Mn |
| Mar 31, 2022 | 50,000.00 |
| Mar 31, 2020 | -3.09 Mn |
| Mar 31, 2017 | -1.07 Mn |
| Dec 31, 2016 | 73,000.00 |
| Mar 31, 2016 | -1.40 Mn |
| Dec 31, 2015 | 445,000.00 |
| Mar 31, 2015 | 2,029.00 |
| Mar 31, 2014 | -4,988.00 |
| Dec 31, 2013 | 1,885.00 |
| Sep 30, 2013 | 1,507.00 |
| Jun 30, 2013 | 1,596.00 |
| Mar 31, 2013 | -343,594.00 |
| Dec 31, 2012 | -453.00 |
| Sep 30, 2012 | -9,735.00 |
| Jun 30, 2012 | -31,710.00 |
| Mar 31, 2012 | -2.63 Mn |
| Mar 31, 2011 | 4.58 Mn |
| Dec 31, 2010 | -20,212.00 |